CD95 ligand expression as a criterion of malignant transformation in breast cancer
Müschen M, Beckmann M. CD95 ligand expression as a criterion of malignant transformation in breast cancer. The Journal Of Pathology 2000, 191: 468-469. PMID: 10918226, DOI: 10.1002/1096-9896(200008)191:4<468::aid-path647>3.0.co;2-j.Peer-Reviewed Original Research